Teresa L. Young, See Remarks at Seres Therapeutics, Inc. (MCRB), sold 735 shares at $0.54 ($397) on 2024-11-18, disclosed to the SEC on 2024-11-19.
Scheduled sale ($397) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MCRB | SELL | 2025-08-19 | $982 | — | Filing → |
| MCRB | SELL | 2025-05-19 | $459 | — | Filing → |
| MCRB | SELL | 2025-02-19 | $3K | — | Filing → |